All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

10

Reset

10 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SHR-1918Phase 37 trials

    Beijing Suncadia Pharmaceuticals Co., Ltd · Homozygous Familial Hypercholesterolemia, Hyperlipidemia, Hypercholesterolemia

  • DR10624Phase 35 trials

    Zhejiang Doer Biologics Co., Ltd. · Severe Hypertriglyceridemia, Hypertriglyceridemia, Severe Hypertriglyceridemia (sHTG)

  • PegozaferminBIO89-100Phase 33 trials

    Roche (Genentech) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Severe Hypertriglyceridemia

  • MAR001Phase 23 trials

    Marea Therapeutics · Hypertriglyceridemia

  • RBD5044Phase 22 trials

    Ribocure Pharmaceuticals AB · Dyslipidemias, Hypertriglyceridemia

  • ION775Phase 21 trial

    Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia

  • JMT202Phase 21 trial

    Shanghai JMT-Bio Inc. · Hypertriglyceridemia

  • MN-001Phase 21 trial

    MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease

  • RN0361Phase 21 trial

    Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome

  • SolbinsiranLY3561774Phase 21 trial

    Eli Lilly · Severe Hypertriglyceridemia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.